Boston Financial Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,764
| Closed | -$249K | – | 346 |
|
|
2024
Q3 | $249K | Sell |
2,764
-1,431
| -34% | -$120K | 0.01% | 297 |
|
|
2024
Q2 | $330K | Sell |
4,195
-57
| -1% | -$4.67K | 0.01% | 276 |
|
|
2024
Q1 | $371K | Sell |
4,252
-1,032
| -20% | -$88.1K | 0.01% | 274 |
|
|
2023
Q4 | $435K | Buy |
5,284
+57
| +1% | +$4.34K | 0.01% | 255 |
|
|
2023
Q3 | $410K | Sell |
5,227
-5,460
| -51% | -$457K | 0.02% | 243 |
|
|
2023
Q2 | $942K | Buy |
10,687
+3,288
| +44% | +$283K | 0.03% | 189 |
|
|
2023
Q1 | $597K | Sell |
7,399
-4,311
| -37% | -$351K | 0.02% | 214 |
|
|
2022
Q4 | $910K | Buy |
11,710
+431
| +4% | +$34.9K | 0.04% | 184 |
|
|
2022
Q3 | $911K | Buy |
11,279
+1,642
| +17% | +$148K | 0.04% | 172 |
|
|
2022
Q2 | $865K | Buy |
9,637
+382
| +4% | +$38.7K | 0.04% | 166 |
|
|
2022
Q1 | $1.03M | Buy |
9,255
+2,509
| +37% | +$265K | 0.04% | 162 |
|
|
2021
Q4 | $698K | Buy |
6,746
+312
| +5% | +$36.1K | 0.03% | 167 |
|
|
2021
Q3 | $807K | Buy |
6,434
+1,391
| +28% | +$180K | 0.03% | 152 |
|
|
2021
Q2 | $626K | Hold |
5,043
| – | – | 0.03% | 158 |
|
|
2021
Q1 | $596K | Buy |
5,043
+25
| +0.5% | +$2.93K | 0.03% | 156 |
|
|
2020
Q4 | $588K | Sell |
5,018
-200
| -4% | -$22K | 0.03% | 154 |
|
|
2020
Q3 | $542K | Sell |
5,218
-121
| -2% | -$12.2K | 0.03% | 162 |
|
|
2020
Q2 | $490K | Sell |
5,339
-37
| -0.7% | -$3.55K | 0.03% | 163 |
|
|
2020
Q1 | $485K | Sell |
5,376
-187
| -3% | -$19.9K | 0.03% | 161 |
|
|
2019
Q4 | $631K | Sell |
5,563
-889
| -14% | -$97.6K | 0.03% | 152 |
|
|
2019
Q3 | $701K | Sell |
6,452
-126
| -2% | -$13.1K | 0.04% | 152 |
|
|
2019
Q2 | $641K | Sell |
6,578
-307
| -4% | -$28K | 0.04% | 158 |
|
|
2019
Q1 | $627K | Sell |
6,885
-834
| -11% | -$74.6K | 0.04% | 165 |
|
|
2018
Q4 | $702K | Sell |
7,719
-890
| -10% | -$83.2K | 0.05% | 157 |
|
|
2018
Q3 | $847K | Sell |
8,609
-921
| -10% | -$85.1K | 0.05% | 173 |
|
|
2018
Q2 | $816K | Sell |
9,530
-2,725
| -22% | -$228K | 0.06% | 160 |
|
|
2018
Q1 | $983K | Hold |
12,255
| – | – | 0.07% | 160 |
|
|
2017
Q4 | $990K | Sell |
12,255
-1,245
| -9% | -$99.7K | 0.07% | 168 |
|
|
2017
Q3 | $1.05M | Sell |
13,500
-400
| -3% | -$33.2K | 0.07% | 165 |
|
|
2017
Q2 | $1.23M | Sell |
13,900
-1,525
| -10% | -$129K | 0.09% | 164 |
|
|
2017
Q1 | $1.24M | Sell |
15,425
-848
| -5% | -$66.2K | 0.09% | 167 |
|
|
2016
Q4 | $1.16M | Buy |
16,273
+410
| +3% | +$32.2K | 0.09% | 174 |
|
|
2016
Q3 | $1.37M | Sell |
15,863
-263
| -2% | -$22.9K | 0.11% | 162 |
|
|
2016
Q2 | $1.4M | Sell |
16,126
-312
| -2% | -$25.2K | 0.11% | 160 |
|
|
2016
Q1 | $1.23M | Sell |
16,438
-12,092
| -42% | -$911K | 0.19% | 113 |
|
|
2015
Q4 | $2.19M | Sell |
28,530
-2,726
| -9% | -$205K | 0.31% | 95 |
|
|
2015
Q3 | $2.09M | Sell |
31,256
-2,827
| -8% | -$208K | 0.3% | 96 |
|
|
2015
Q2 | $2.53M | Sell |
34,083
-1,305
| -4% | -$99.7K | 0.32% | 93 |
|
|
2015
Q1 | $2.76M | Sell |
35,388
-87
| -0.2% | -$6.59K | 0.35% | 95 |
|
|
2014
Q4 | $2.56M | Hold |
35,475
| – | – | 0.32% | 96 |
|
|
2014
Q3 | $2.2M | Sell |
35,475
-3,389
| -9% | -$215K | 0.29% | 102 |
|
|
2014
Q2 | $2.48M | Sell |
38,864
-7,202
| -16% | -$438K | 0.33% | 91 |
|
|
2014
Q1 | $2.83M | Sell |
46,066
-923
| -2% | -$53.8K | 0.38% | 79 |
|
|
2013
Q4 | $2.7M | Sell |
46,989
-7,155
| -13% | -$406K | 0.37% | 77 |
|
|
2013
Q3 | $2.88M | Sell |
54,144
-1,700
| -3% | -$91.5K | 0.43% | 72 |
|
|
2013
Q2 | $2.87M | Buy |
+55,844
| New | +$2.76M | 0.44% | 69 |
|
Other funds holding MDT
Boston Financial Management's MDT Position: Q4 2024 in Review
Boston Financial Management sold out of Medtronic (MDT) in Q4 2024, closing a stake of 2,764 shares — an estimated $249K sold.
Boston Financial Management first reported a position in MDT in Q2 2013 and held it in 46 quarters. The position peaked at $2.88M in Q3 2013. 2,124 funds tracked by Wall St. Rank hold MDT as of Q4 2024.
- Boston Financial Management reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
- Boston Financial Management sold 2,764 Medtronic shares in Q4 2024, an estimated $249K.
- Boston Financial Management first reported a position in Medtronic in Q2 2013 and held it in 46 quarters.
- Boston Financial Management's Medtronic position peaked at $2.88M in Q3 2013.
- 2,124 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.